- Home
- TRIN vs ALVO Comparison
TRIN vs ALVO Comparison
Compare TRIN & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TRIN | ALVO |
|---|---|---|
| Founded | 2007 | 2013 |
| Country | United States | Luxembourg |
| Employees | N/A | 1032 |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TRIN | ALVO |
|---|---|---|
| Price | $14.37 | $3.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $16.00 | $8.00 |
| AVG Volume (30 Days) | ★ 1.3M | 643.0K |
| Earning Date | 05-06-2026 | 03-18-2026 |
| Dividend Yield | ★ 14.28% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $29.43 | $37.82 |
| Revenue Next Year | $6.80 | $25.80 |
| P/E Ratio | ★ $7.18 | $18.20 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.97 | $3.03 |
| 52 Week High | $17.20 | $11.85 |
Technical Indicators
Market Signals| Indicator | TRIN | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 40.48 | 37.57 |
| Support Level | $14.35 | N/A |
| Resistance Level | $15.28 | $4.17 |
| Average True Range (ATR) | 0.28 | 0.19 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 27.01 | 35.29 |
Price Performance
Historical ComparisonAbout TRIN Trinity Capital Inc.
Trinity Capital Inc is a closed-end, non-diversified management investment company. The company is engaged in providing debt, including loans and equipment financings, to growth-stage companies, including venture-backed companies and companies with institutional equity investors. Its equipment financings involve loans for general or specific use, including acquiring equipment, secured by the equipment or other assets of the portfolio company.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.